The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-(4-(2H-tetrazol-5-yl)pyridin-2-yl)-1-methyl-1H-imidazol-5-yl)-2-fluoro-N-phenylbenzamide ID: ALA4294755
PubChem CID: 90407384
Max Phase: Preclinical
Molecular Formula: C23H17FN8O
Molecular Weight: 440.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cnc(-c2cc(-c3nn[nH]n3)ccn2)c1-c1ccc(F)c(C(=O)Nc2ccccc2)c1
Standard InChI: InChI=1S/C23H17FN8O/c1-32-13-26-20(19-12-15(9-10-25-19)22-28-30-31-29-22)21(32)14-7-8-18(24)17(11-14)23(33)27-16-5-3-2-4-6-16/h2-13H,1H3,(H,27,33)(H,28,29,30,31)
Standard InChI Key: JUOZTTXGXKVWCW-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
21.7489 -6.5772 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5335 -6.3201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5335 -5.4951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7489 -5.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2599 -5.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7849 -5.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1974 -6.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0224 -6.6235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4349 -5.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0224 -5.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1974 -5.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1989 -5.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7855 -4.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1190 -3.7287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5063 -3.1762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7915 -3.5881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9625 -4.3953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4933 -4.4596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0481 -3.8474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7949 -3.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9874 -2.8896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4336 -3.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6897 -4.2889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7326 -2.1050 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.3481 -2.4509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1548 -2.6241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0947 -1.6658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7080 -2.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5117 -2.1867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0647 -1.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8114 -0.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0001 -0.6181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4506 -1.2306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
9 5 1 0
3 12 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 13 2 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
4 18 1 0
21 24 1 0
20 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 440.44Molecular Weight (Monoisotopic): 440.1509AlogP: 3.72#Rotatable Bonds: 5Polar Surface Area: 114.27Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.84CX Basic pKa: 2.82CX LogP: 3.94CX LogD: 2.67Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -1.74
References 1. (2016) Histone demethylase inhibitors,